Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/11490
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorRoa Linares, Vicky Constanza-
dc.contributor.authorGamito, Ana Maria-
dc.contributor.authorCastro, Maria Angeles-
dc.contributor.authorMesa Arango, Ana Cecilia-
dc.contributor.authorMartin, Arturo San Feliciano-
dc.contributor.authorTangarife Castano, Veronica-
dc.contributor.authorBetancur Galvis, Liliana Amparo-
dc.contributor.authorDel Corral, Jose Maria Migel-
dc.contributor.authorFrancesch, Andres-
dc.date.accessioned2019-07-23T14:40:08Z-
dc.date.available2019-07-23T14:40:08Z-
dc.date.issued2015-
dc.identifier.citationRoa Linares VC et al. New 1,4-anthracenedione derivatives with fused heterocyclic rings: Synthesis and biological evaluation. RSC Advances. 2015;5(2):1244-1261spa
dc.identifier.issn2046-2069-
dc.identifier.urihttp://hdl.handle.net/10495/11490-
dc.description.abstractABSTARCT: Several terpenylquinones derived from 1,4-anthracenedione (1,4-anthracenequinone, AQ) have been prepared by addition or substitution nucleophilic reactions and further transformed into extended polycyclic systems, which mainly kept the 1,4-quinone moiety fused to different nitrogen-heterocyclic rings (pyrrole, imidazole, pyrazine or quinoxaline) into the structure. The compounds synthesized were evaluated for their antineoplastic, antifungal and antiviral activities. GI50 antineoplastic values remained under μM levels for AQs, while the heterocyclic derivatives showed antifungal MIC values in the low μg mL-1 range against yeasts and filamentous fungi. Only few compounds displayed a discrete non-selective antiherpetic activity in the μg mL-1 range. This journal is © The Royal Society of Chemistry 2015.spa
dc.format.extent17spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherRoyal Society of Chemistryspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsAtribución 2.5*
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.subjectOrganic compounds-
dc.subjectAntineoplastic-
dc.subjectAntiviral activities-
dc.subjectBiological evaluation-
dc.subjectFilamentous fungi-
dc.subjectHeterocyclic rings-
dc.subjectNucleophilic reaction-
dc.subjectPolycyclic systems-
dc.subjectQuinoxalines-
dc.titleNew 1,4-anthracenedione derivatives with fused heterocyclic rings: Synthesis and biological evaluationspa
dc.title.alternativeRoa Linares et al. New 1,4-anthracenedione derivatives with fused heterocyclic rings: Synthesis and biological evaluationspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.identifier.doi10.1039/c4ra11726c-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitleRoyal Society of Chemistryspa
oaire.citationstartpage1244spa
oaire.citationendpage1261spa
oaire.citationvolume5spa
oaire.citationissue2spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeReino Unidospa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.relation.ispartofjournalabbrevRSC Advancesspa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CastroMariaAngeles_2015_AnthracenedioneHeteocyclicBiological.pdfArtículo de Revista610.29 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons